Prevention of Irreversible Damage in IBD

08/01/2018

<iframe allowFullScreen frameborder="0" height="564" mozallowfullscreen src="https://player.vimeo.com/video/282714799" webkitAllowFullScreen width="640"></iframe>

Related Content

Gastroenterology
Gastroenterology
Counseling Pregnant Patients Regarding Therapy Modification
08/06/2018
08/06/2018
Lipid & Metabolic
Louis Kuritzky, MD
Lipid & Metabolic
CRS 2014: We Know About the Benefits and Risks of Statins
10/14/2014
2014 Summit Faculty interview with Louis Kuritzky, MD, about some of the benefits and risks of statin treatment, including the risk of developing diabetes.&nbsp;
10/14/2014
Rheumatology
Vibeke Strand, MD
Rheumatology
Vibeke Strand, MD, on the Future of JAK Inhibitors for Immune-Mediated Inflammatory Diseases
06/23/2019
In this video, Vibeke Strand, MD, highlights current JAK inhibitors for the treatment of immune-mediated inflammatory diseases, how they may be used in the future, and more.
06/23/2019
Hair Loss
brett king dermatology
Hair Loss
Brett A. King, MD, PhD, on an Overview of Janus Kinase Inhibitors for Alopecia Areata
08/10/2017
In this video, Dr Brett A. King from Yale School of Medicine talks about what JAK inhibitors are, their adverse effect profile, and more.
08/10/2017
COVID-19
Ryan Ungaro
COVID-19
Ryan Ungaro, MD, on COVID-19 in Patients With IBD
06/27/2020
Ryan Ungaro, MD, recaps his presentation on how COVID-19 has affected patients with IBD in New York.
06/27/2020